Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt in Conjunction With Topical Prednisolone Acetate 1% Treating Pain, and inflamMation Following Corneal Transplant Surgery Compared to Topical Prednisolone Acetate 1%.

NCT04521140 is registered in ClinicalTrials.gov with Nicole Fram M.D. as lead sponsor.

NCT NCT04521140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04521140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt in Conjunction With Topical Prednisolone Acetate 1% Treating Pain, and inflamMation Following Corneal Transplant Surgery Compared to Topical Prednisolone Acetate 1%.
Lead sponsor
Nicole Fram M.D.
Phase
Phase 4
Overall status
Completed
Start date
October 16, 2020
Completion date
January 4, 2023
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anterior chamber inflammation, corneal defect, corneal edema, corneal transplant, intraocular pressure, ocular pain, penetrating keratoplasty